期刊文献+

鹿瓜多肽对强直性脊柱炎病情的改善作用 被引量:2

Evaluation on short-term efficacy of cervus and cucumis polypeptide injection in treatment of ankylosing spondylitis
原文传递
导出
摘要 目的采用鹿瓜多肽注射液(cervus and cucumis polypeptid einjection,CCPI)治疗强直性脊柱炎(ankylosing spondylitis,AS)并进行为期3周的临床观察,以评价其对AS病情的改善作用和安全性。方法住院治疗的AS患者108例随机分为实验组和对照组各54例,对照组采用非甾体类抗炎药(NSAIDs)和来氟米特(leflunomide,LEF)治疗,实验组则在此基础上给予CCPI治疗,疗程共3周,观察腰背痛、腰背晨僵时间、巴斯脊柱炎活动指数(BASDAI)、巴斯脊柱炎功能指数(BASFI)、ESR和CRP等指标的变化及不良反应。结果两组患者治疗3周与入组时比较,腰背痛发生率明显下降,腰背部晨僵时间显著减短,BASDAI和BASFI评分明显改善,炎性指标ESR和CRP显著下降,差异均有统计学意义(P〈0.05);经治疗3周两组间比较,腰背痛发生率、腰背部晨僵时间、BASDAI、BASFI、ESR和CRP,实验组较对照组均有显著改善。差异有统计学意义(P〈0.05)。不良反应主要以胃肠道反应为主,有个别皮疹发生,两组间差异无统计学意义。结论CCPI用于治疗AS有病情改善作用,且不良反应较轻,可作为AS的辅助治疗药物。 Objective To evaluate the short-term efficacy and safety of cervus and cucumis polypeptide injection(CCPI) in treatment of ankylosing spondylitis(AS). Methods 108 patients with AS were randomized into two groups :54 patients took NSAIDs and leflunomide(LEF) (control group), and 54 patients were treated with NSAIDs, LEF and CCPI (test group). The treatment was lasted for three weeks. The observation included the prevalence of low back pain, time of morning stiffness, Bath AS disease activity index ( BASDAI ), Bath AS functional index(BASFI) ,ESR,C-reactive protein(CRP) and side effects. SPSS16. 0 statistics software was used to analyze the data. Results After treatment for three weeks, the prevalence of low back pain, the time of morn- ing stiffness, BASDAI, BASFI, ESR and CRP were significantly lower than those at administration( P 〈 0. 05 ), and there were no table differences between the two groups too, ( P 〈 0. 05 ). Gastrointestinal symptoms were the main side effects, but there were no significance between the two groups. Conclusion CCPI is an effective med- icine in the treatment of AS, which could modify the disease activities, and its side effect is mild. It is suggested that CCPI can be used as an adjuvant medication in the treatment of AS.
出处 《中国临床实用医学》 2010年第5期8-9,共2页 China Clinical Practical Medicine
关键词 脊柱炎 强直性 鹿瓜多肽 来氟米特 Spondylitis Ankylosing Cervus and cucumis polypeptide injection Leflunomide
  • 相关文献

参考文献9

  • 1van der Linden S, van der Heijde D. Ankylosing spondylitis. In: Ruddy S, Harris JR ED, Sledge CB, editors. Kelley' s textbook of rheumatology. 6th edition. Philadelphia:W. B. Saunders Company, 2001 : 1039-1054.
  • 2van der Linden S, Valkenburg HA, Cats A, Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum, 1984,27 : 361-368.
  • 3Garrett S,Jenkinson T,Kennedy LG,et al. A new approach to defining disease status in ankylosing spondylitis : the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol, 1994, 21: 2286-2291.
  • 4Calin A, Garrett S,Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol, 1994, 21:2281-2285.
  • 5Dalyan M,Guner A,Tuncer S,Bilgic A,et al. Disability in ankylosing spondylitis. Disabil Rehabil, 1999,21:74-79.
  • 6Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the reatment of axial and peripheral articular manifestations of seronegative spondylar-thropathies. Arthritis Rheum, 1999, 42 : 2325 -2329.
  • 7赵福涛,管剑龙,韩星海.甲氨蝶呤治疗强直性脊柱炎髋关节病变的临床研究[J].中华风湿病学杂志,2007,11(4):213-216. 被引量:11
  • 8尚娟.松梅乐注射液治疗类风湿性关节炎[J].医药论坛杂志,2005,26(20):55-55. 被引量:6
  • 9鞠大宏,贾红伟,吴皓,肖诚,周桂琴,赵宏艳,滕静如,潘静华.鹿瓜多肽注射液对CⅡ诱导的免疫性关节炎大鼠血清TNF-α、IL-6以及CⅡ抗体活性的影响[J].中国中医基础医学杂志,2003,9(11):17-20. 被引量:19

二级参考文献19

  • 1中华外科杂志编辑部.股骨头缺血性坏死专题讨论会纪要[J].中华外科杂志,1994,32:549-549.
  • 2Trentham DE, et al. autoimmunity to type Ⅱ collagen: an experimental model of arthritis. J Exp Med, 1977,146: 857-868.
  • 3Choi EK, Et al.antibodies to type Ⅱ collagen in SLE:a role in the pathogenesis of deforming arthristis. J Immunol-cellbiol, 1990,68( Pt1 ) :27.
  • 4Cutolo, M and accuado, S: sex hormones, HLA and rheumatoid arthritis. J Clin Exp Rheumatol, 1991,9:641.
  • 5clague, RB and moore, L J: IgG and IgM antibody to native type Ⅱ collagen in rheumatoid arthritis serum and synovial fluid. J Arthritis Rheum, 1984,27:1370.
  • 6Hansson, Ⅰ et al : aonstant darkness enhances autoimmunity to type Ⅱ collagen and exaggerates development of collagen induced arthritis in DBA/1 mice. J Neuroimmunol, 1990,27:79.
  • 7Guerne PA, Zuraw BL, Vaughan JH, et al. Synovium as a source of intrlukin 6 in vitro contribution to local and systemic manifestations of arthritis. J Clin Invest, 1989,83 :585-592.
  • 8Van Snick J, Interlukin-6: an overview. J Aunu Rev Immunol, 1990,8 : 253-258.
  • 9中华人民共和国卫生部.中药新药临床研究指导原则 第一辑[Z].,1993.215-218.
  • 10Van der Linden S, van der Heijde D. Ankylosing spondylitis//Ruddy S, Harris ED Jr, Sledge CB. Kelley's textbook of rheumatology. 6th ed. Philadelphia: WB. Sannders Company, 2001:1039-1054.

共引文献30

同被引文献32

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部